share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Officer Klima Thomas J

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Officer Klima Thomas J

bluebird bio | 4：持股变动声明-高管 Klima Thomas J
美股SEC公告 ·  2024/10/03 04:11

Moomoo AI 已提取核心信息

Thomas J Klima, associated with bluebird bio, Inc. [BLUE], completed a stock transaction on September 30, 2024. The transaction involved the sale of 1,006 shares of common stock at a price of $0.5257 per share. Following the sale, Klima's direct holdings in the company amounted to 170,000 shares. The total market value of the disposed shares was $528.85. This transaction was part of a broader event where Klima also acquired 50,000 shares at no cost, which is typically indicative of a grant or award. The transactions were conducted under the direct ownership category and have been reported as completed.
Thomas J Klima, associated with bluebird bio, Inc. [BLUE], completed a stock transaction on September 30, 2024. The transaction involved the sale of 1,006 shares of common stock at a price of $0.5257 per share. Following the sale, Klima's direct holdings in the company amounted to 170,000 shares. The total market value of the disposed shares was $528.85. This transaction was part of a broader event where Klima also acquired 50,000 shares at no cost, which is typically indicative of a grant or award. The transactions were conducted under the direct ownership category and have been reported as completed.
Thomas J Klima，与bluebird bio，Inc. [BLUE]有关，于2024年9月30日完成了一笔股票交易。该交易涉及以每股0.5257美元的价格出售1006股普通股。销售后，Klima在该公司的直接持股达到了170,000股。处置股份的总市值为528.85美元。此交易是Klima参与的更广泛事件的一部分，他还免费获得了50,000股股份，这通常表明获得了授予或奖励。这些交易是在直接所有权类别下进行的，并已报告为已完成。
Thomas J Klima，与bluebird bio，Inc. [BLUE]有关，于2024年9月30日完成了一笔股票交易。该交易涉及以每股0.5257美元的价格出售1006股普通股。销售后，Klima在该公司的直接持股达到了170,000股。处置股份的总市值为528.85美元。此交易是Klima参与的更广泛事件的一部分，他还免费获得了50,000股股份，这通常表明获得了授予或奖励。这些交易是在直接所有权类别下进行的，并已报告为已完成。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Moleculin Biotech
    MBRX
    -- 2.1800
    Allogene Therapeutics
    ALLO
    -- 2.040
    CNS Pharmaceuticals
    CNSP
    -- 0.1400
    Tenaya Therapeutics
    TNYA
    -- 1.200
    LEXARIA BIOSCIENCE CORP C/WTS(TO PUR COM)
    LEXXW
    -- 0.3400
    解锁完整榜单
    热门讨论
    特朗普2.0时代开启，全球市场会如何演变？
    🎙️讨论： 1. 关税政策将如何影响美股、黄金、比特币等核心资产的走势？ 2. 在此背景下，有哪些投资机会值得关注？你会如何布局？ 展开
    MicroStrategy 2024年第四季度业绩电话会
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。